RNA-Protein Interaction between RN7SKP26 and USP46: Potential Drug Target and Biomarker

Target Name: RN7SKP26

NCBI ID: G106479106

Other Name(s): RN7SK pseudogene 26

RNA-Protein Interaction between RN7SKP26 and USP46: Potential Drug Target and Biomarker

The RNA-protein interactions are a crucial aspect of gene regulation, where RNA molecules act as scaffolds to recruit protein partners for protein synthesis. One of the well-known RNA-protein interactions is the RNA-protein interaction between RNA7SKP26 and its protein partner. RN7SKP26 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. In this article, we will explore the RNA-protein interaction between RN7SKP26 and its protein partner, its potential implications as a drug target, and its potential utility as a biomarker.

Structure and Expression

RNA7SKP26 is a 26nt RNA molecule that contains 10 exons. It is expressed in various tissues, including brain, heart, and liver, and has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation. RNA7SKP26 has been shown to interact with several proteins, including the protein encoded by the gene USP46. USP46 is a non-coding RNA molecule that is expressed in various tissues and has been shown to play a role in various cellular processes, including cell signaling and transcriptional regulation.

The RNA-protein interaction between RN7SKP26 and USP46 is a complex process that involves multiple interacting proteins. The interaction between RN7SKP26 and USP46 is proposed to be driven by the conservation of multiple functional domains in both RNA and protein molecules. These functional domains include a leucine -rich repeat (LRR), a conserved protein-coding region, and a structural domain.

Drug Target Potential

The RNA-protein interaction between RN7SKP26 and USP46 is a potential drug target for various diseases. One of the potential benefits of targeting RN7SKP26 is its potential to inhibit the activity of USP46, which has been shown to play a role in various cellular processes, including cell signaling and transcriptional regulation. This can lead to the inhibition of cellular processes that are associated with the disease, such as cell proliferation, migration, and angiogenesis.

In addition, the RNA-protein interaction between RN7SKP26 and USP46 is also a potential biomarker for various diseases. The expression of RN7SKP26 and USP46 may be regulated by various factors, including gene expression, post-transcriptional modification, and protein-protein interactions. This can lead to changes in cellular behavior and appearance, which can be used as a biomarker for various diseases. For example, decreased expression of RN7SKP26 and USP46 may be associated with cancer, while increased expression may be associated with neurodegenerative diseases.

Conclusion

In conclusion, the RNA-protein interaction between RN7SKP26 and USP46 is a complex process that involves multiple interacting proteins. The potential drug target potential of RN7SKP26 is based on its interaction with USP46, which has been shown to play a role in various cellular processes. The potential biomarker potential of RN7SKP26 is based on its expression and regulation by various factors, including gene expression and post-transcriptional modification. Further research is needed to fully understand the role of RN7SKP26 as a drug target or biomarker for various diseases.

Protein Name: RN7SK Pseudogene 26

More Common Targets